Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Scott

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Nanotechnology|August 16, 2011
Fractal electronic devices: simulation and implementationM S Fairbanks, D N McCarthy, S A Scott, et al.
The Pharmacogenomics Journal|April 12, 2012
Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypesS Martis, I Peter, J-S Hulot, et al.
Gynecologic Oncology|April 1, 2017
Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancerS A Scott, C van der Zanden, E Cai, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1995
Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalisS A Scott, E J Mufson, J A Weingartner, et al.
Annals of Neurology|October 1, 1992
Amygdala cell loss and atrophy in Alzheimer's diseaseS A Scott, S T DeKosky, D L Sparks, et al.
Experimental Neurology|November 1, 1994
Neurite degeneration elicited by apolipoprotein E peptidesK A Crutcher, M A Clay, S A Scott, et al.
Physical Review Letters|January 15, 2011
Quantitative determination of contributions to the thermoelectric power factor in Si nanostructuresHyuk Ju Ryu, Z Aksamija, D M Paskiewicz, et al.
Proceedings. Biological Sciences|January 22, 1992
Levels of inositol metabolites within normal myeloid blast cells and changes during their differentiation towards monocytesC M Bunce, P J French, W N Patton, et al.
Clinical Pharmacology and Therapeutics|July 1, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapyS A Scott, K Sangkuhl, E E Gardner, et al.
Clinical Pharmacology and Therapeutics|July 10, 2016
Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic TestingA Owusu Obeng, T Kaszemacher, N S Abul-Husn, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Nanotechnology|August 16, 2011
Fractal electronic devices: simulation and implementationM S Fairbanks, D N McCarthy, S A Scott, et al.
The Pharmacogenomics Journal|April 12, 2012
Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypesS Martis, I Peter, J-S Hulot, et al.
Gynecologic Oncology|April 1, 2017
Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancerS A Scott, C van der Zanden, E Cai, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1995
Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalisS A Scott, E J Mufson, J A Weingartner, et al.
Annals of Neurology|October 1, 1992
Amygdala cell loss and atrophy in Alzheimer's diseaseS A Scott, S T DeKosky, D L Sparks, et al.
Experimental Neurology|November 1, 1994
Neurite degeneration elicited by apolipoprotein E peptidesK A Crutcher, M A Clay, S A Scott, et al.
Physical Review Letters|January 15, 2011
Quantitative determination of contributions to the thermoelectric power factor in Si nanostructuresHyuk Ju Ryu, Z Aksamija, D M Paskiewicz, et al.
Proceedings. Biological Sciences|January 22, 1992
Levels of inositol metabolites within normal myeloid blast cells and changes during their differentiation towards monocytesC M Bunce, P J French, W N Patton, et al.
Clinical Pharmacology and Therapeutics|July 1, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapyS A Scott, K Sangkuhl, E E Gardner, et al.
Clinical Pharmacology and Therapeutics|July 10, 2016
Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic TestingA Owusu Obeng, T Kaszemacher, N S Abul-Husn, et al.
Pageof 10